Rule 1: Molecules containing nitro groups (-NO2) can react adversely due to their increased reactivity, potentially causing toxic reactions or side effects. 
Rule 2: Molecules containing carbonyl groups (-C=O), specifically in conjugation with other double bonds, can increase reactivity and toxicity potential.
Rule 3: Molecules with long carbon chains or complex structures might have difficulty crossing cell membranes, possibly diminishing efficacy or effectiveness.
Rule 4: Molecules with sulfonyl groups (-SO2-) may have the potential to cause adverse effects.
Rule 5: Molecules with a conjugated system of double bonds can cause adverse effects.
Rule 6: Molecules with cyano groups can cause potential side effects due to their inherent toxicity.
Rule 7: Carboxylic acid groups can cause adverse effects, such as skin irritation, respiratory problems, and other health issues due to their potential irritating nature. 
Rule 8: Long carbon chains can lead to potential health issues because of their hydrophobic feature making them hard to digest and absorb.
Rule 9: Molecules with sulfonamide groups (-SO2NH-) may have the potential to cause adverse effects, requiring further research to confirm.
Rule 10: Molecules with two or more negatively charged oxygen atoms potentially cause adverse effects.
Rule 11: Molecules containing metal ions have the potential to cause adverse effects due to their ability to disrupt normal biological processes.
Rule 12: The size, shape, charge, and polarity can influence a molecule's interaction with biological systems, potentially causing harm.
Rule 13: The presence of bromine atoms could potentially cause adverse effects due to possible toxicity.
Rule 14: Thiophene ring presence indicates potential risk for adverse effects due to the known toxic properties of sulfur.
Rule 15: Molecules containing sulfonyl (SO2R) or phosphate groups (PO4R) may potentially cause adverse effects due to these being common in drugs linked to serious side effects.
Rule 16: Halogen atoms present in a molecule (for instance, chlorine or fluorine) may potentially cause adverse effects as these are often present in hazardous chemicals.
Rule 17: Molecules with negatively charged ions such as [OH-] or [Cl-] or metal ions (Mn+2, Gd, Na+, or Ca+2) or functional groups like C=ON, CN, COOR, or SO3R, could cause adverse effects.
Rule 18: Functional groups like "-NO_2" or "-COOH" in the molecular structure may lead to potential toxicity.
Rule 19: Molecules containing a cyano group (-CN) or a carbonyl group (-C=O), may have the potential to cause adverse effects.
Rule 20: Molecules containing a halogen atom with signs of reactivity or increased biological interaction may lead to potential adverse effects.
Rule 21: Molecules with chlorine atoms and carbonyl groups in the structure may increase reactivity and lead to potential side effects.
Rule 22: Molecules with sulfur-selenium bond (S=[Se]=S) could potentially lead to various negative effects due to possible toxic levels of sulfur and selenium.
Rule 23: Functional groups like a sulfonyl group (-SO2-) or a nitro group (-NO2) can potentially cause adverse effects.
Rule 24: Presence of fluoride ions and carbonyl groups can enhance toxicity.
Rule 25: Phosphate groups, sulfonamide groups or gadolinium ions present in a molecule, could potentially cause adverse effects.
Rule 26: If chlorine atom is bonded to an sp3 carbon, there is a potential for adverse effects. 
Rule 27: Molecules containing potential lipophilic functional groups, such as chlorine and carbonyl groups, may cause adverse effects due to their enhanced reactivity.
Rule 28: Molecules with multiple or aromatic rings may cause potential side effects due to their low solubility and high lipophilicity.
Rule 29: Molecules that contain negatively charged ions like [OH-] or [Cl-], metal ions, or functional groups like C=ON, CN, COOR, or SO3R, have a potential to cause adverse effects. 
Rule 30: Molecules with "-NO_2", "-COOH", or halogens in the structure, or that are large in size (greater than 500 Daltons) or contain multiple aromatic rings, can cause potential adverse effects or toxicity.
Rule 31: Any molecule containing sulfonamide groups or nitro groups has the potential to trigger adverse effects.
Rule 32: Molecules with potential lipophilic functional groups, such as chlorine and carbonyl groups, may cause adverse effects due to their enhanced reactivity.
Rule 1: If a molecule contains a functional group such as "CCON" or "CCS", then it may potentially cause adverse effects as these groups are commonly found in drugs associated with side effects.
Rule 2: Molecule containing a halogen atom such as chlorine or fluorine may cause adverse effects, as halogens often used in drug design can increase the likelihood of side effects.
Rule 3: Molecules with a nitro group (-NO2) may cause adverse effects due to the known toxicity of nitro compounds. 
Rule 4: If a compound contains a bromine atom or a platinum ion, it may have the potential to cause adverse effects. This rule applies to molecules represented by specific SMILES strings. 
Rule 5: Compounds containing a cyano group (-CN) bonded to an alkene may potentially cause adverse effects due to the reactivity of cyano groups.
Rule 6: A molecule with a sulfonyl group (-SO2R) and a halogen atom such as chlorine (Cl) or fluorine (F) may cause adverse effects.
Rule 7: A molecule with a heterocyclic ring system may have the potential to cause adverse effects. 
Rule 8: A molecule containing a functional group, such as a carbonyl group or a double bond between carbon atoms, may have the potential to cause adverse effects.
Rule 9: A molecule with a nitro group (-NO2) or a nitrile group (-CN) may cause adverse effects. 
Rule 10: Molecules that contain a sulfonamide group (-SO2NH-) may potentially cause adverse effects.
Rule 11: The existence of a functional group like "-COOH" or "-OH" in a molecular structure may lead to potential adverse effects due to their ability to interact with other molecules and disrupt their normal functions.
Rule 12: A molecule containing multiple rings or aromatic systems may cause potential adverse effects due to the potential toxicity and interference capacity of these structures with cellular processes. 
Rule 13: Molecular structures with a large number of nitrogen atoms or nitro groups may potentially cause toxicity as they disrupt electron transfer reactions and change cell membrane permeability.
Rule 14: A molecule with a positively charged nitrogen atom bonded to four carbon atoms in a ring structure could potentially cause adverse effects.
Rule 15: If a molecule contains a sulfonyl group (-SO2R), it needs to be evaluated for potential adverse effects.
Rule 16: Those molecules with a nitro group (-NO2), a nitrile group (-CN), or a conjugated system of double bonds may potentially cause adverse effects.
Rule 17: If a molecule contains a sulfonamide group (-SO2NH-) or a sulfate group (-OSO3-), it may have the potential to cause adverse effects.
Rule 18: A molecule containing a chlorine atom bonded to a carbon atom in the ring structure, a nitro group (-NO2), or a sulfonamide group (-SO2NH2) attached to a carbon atom may potentially cause adverse effects. 
Rule 19: A molecule containing a sulfonyl group (-SO2-), nitro group (-NO2-), or a conjugated system of double bonds may have the potential to cause adverse effects.
Rule 20: If a molecule contains a cyano group (-CN), a sulfonyl group (-SO2R), or a phosphate group (-OPO3H2) it may signal potential side effects.
